Consolidated Balance Sheet - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 1,221	$ 1,614
Accounts and notes receivable (net of allowances of $41 million in 2020 and 2019)	4,046	7,376
Accounts and notes receivable—related parties	513	1,134
Inventories	5,331	3,776
Prepaid expenses and other current assets	594	495
Total Current Assets	11,705	14,395
Investments and long-term receivables	13,635	14,571
Net properties, plants and equipment	24,051	23,786
Goodwill	1,425	3,270
Intangibles	880	869
Other assets	1,764	1,829
Total Assets	53,460	58,720
Liabilities
Accounts payable	4,882	8,043
Accounts payable—related parties	440	532
Short-term debt	2,243	547
Accrued income and other taxes	703	979
Employee benefit obligations	301	710
Other accruals	1,960	835
Total Current Liabilities	10,529	11,646
Long-term debt	10,720	11,216
Asset retirement obligations and accrued environmental costs	635	638
Deferred income taxes	5,487	5,553
Employee benefit obligations	1,000	1,044
Other liabilities and deferred credits	1,450	1,454
Total Liabilities	29,821	31,551
Equity
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2020—647,050,977 shares; 2019—647,416,633 shares), Par value	6	6
Capital in excess of par	20,305	20,301
Treasury stock (at cost: 2020—211,771,827 shares; 2019—206,390,806 shares)	(17,116)	(16,673)
Retained earnings	19,168	22,064
Accumulated other comprehensive loss	(991)	(788)
Total Stockholders’ Equity	21,372	24,910
Noncontrolling interests	2,267	2,259
Total Equity	23,639	27,169
Total Liabilities and Equity	$ 53,460	$ 58,720